2019 Speaker Profiles (page under construction)


Richard Levenson, MD, FCAP, is Professor and Vice Chair for Strategic Technologies, Department of Pathology and Laboratory Medicine, UC Davis, where he develops novel imaging technologies. Board-certified in Anatomic Pathology, he received his MD at University of Michigan and pathology training at Washington University. A faculty position at Duke was followed by appointment at Carnegie Mellon University. He subsequently joined Cambridge Research & Instrumentation (now part of PerkinElmer), becoming VP of Research before returning to academia. He has helped develop multispectral microscopy systems and software for molecular pathology and diagnostics, multispectral and three-dimensional small-animal imaging systems, optical dynamic contrast techniques, orientation-independent birefringence microscopy, multiplexed ion-beam imaging, and most recently, real-time slide-free microscopy. He serves on multiple review panels, is section editor for Archives of Pathology and on the editorial board of Laboratory Investigation. Regrettably, he also taught pigeons histopathology and radiology. He is co-founder of MUSE Microscopy, Inc. and a recipient of the UC Davis Chancellor’s Innovator of the Year (2018) award.


Gwen V. Childs, Ph.D.,FAAA, University of Arkansas for Medical Sciences.  Dr. Childs received a B.A. from Whitman College in 1966 and a Ph.D. in Anatomy from the Univ Iowa in 1972 and served on the faculty at the Univ. Nebr, Northwestern University, and the Univ. Texas Medical Branch.  In 2000 she became Chair of Neurobiology and Developmental Sciences at the Univ Arkansas for Medical Sciences.  She was President of The Histochemistry Society and the Association of Anatomy, Cell Biology and Neurobiology Chairs; and is a Fellow of the American Association of Anatomists (FAAA). Her awards include Distinguished Teacher (UTMB), Innovations in Teaching (UAMS) and Outstanding Woman Faculty (UAMS). Her laboratory originally developed novel affinity histochemical and immunohistochemical approaches to identify and unravel the mystery of multipotential pituitary cells, challenging the one-cell-one-hormone paradigm. Current studies focus on how the metabolome communicates with pituitary cells. They are based on discoveries of novel pathways that regulate mRNA translation and thus informed by post-transcriptional regulatory insights.


Peter A. Sims, PhD, Columbia University. Dr. Sims received in Ph.D. in chemistry from Harvard University where he also conducted postdoctoral research, and has been an Assistant Professor at Columbia since 2012. He has served as Director of Systems Biology Graduate Studies since 2016 and Director of the Columbia Single Cell Analysis Core since 2017.  Dr. Sims' Lab at Columbia University Medical Center focuses on the development of new technology for the application of systems biology in biomedicine. We recently developed and applied new experimental and computational methods for cell type-specific, genome-wide analysis of transcription and translation in complex tissues such as the brain. In addition, we have developed new technology for large-scale expression analysis of individual cells by combining cutting-edge microscopy, next-generation sequencing, and microfabrication. We apply these tools in several human disease contexts including brain tumors and other neurological disorders. 


Janis MarieTaube MD, MSc, Director, Division of Dermatopathology, Johns Hopkins University. Dr. Janis Taube is an associate professor of dermatology and pathology at the Johns Hopkins University School of Medicine and a member of the Johns Hopkins Kimmel Cancer Center. Her area of clinical expertise is dermatopathology. Dr. Taube serves as the Director of the Division of Dermatopathology and as the Assistant Director of the Dermatoimmunology Laboratory at the School of Medicine.  Dr. Taube received her undergraduate degree in engineering from Duke University. She earned her M.D. from Tulane University and her M.Sc. in molecular medicine from University College London. She completed her residency in pathology at Johns Hopkins where she also served as the chief resident, before undertaking a dermatopathology fellowship at Stanford University. In 2009, Dr. Taube returned to Johns Hopkins for her certification in the Melanoma Clinic.


Fiona Ginty, Biosciences Technology Manager and Principal Investigator, Biology and Applied Physics, GE Research.  Fiona leads a group of cellular and molecular scientists in Biosciences who are inventing new methods and applications for the life sciences industry, including new cell therapy workflows, forensics, synthetic biology and cell imaging. For the last 10 years, she also led a multidisciplinary program and collaborations to develop a multiplexed imaging platform for fixed tissue, which has led to new insights into tumor biology and immune response. It has been commercialized by GE Research as a service and research platform (MultiOmyx and Cell DIVE). She is Principal Investigator on a NIH RO1 which is investigating apoptosis heterogeneity in colorectal cancer and co-PI with Indiana University which aims to characterize immune response to DCIS. Earlier in her career she led research on osteoporosis, bone health and vitamin D metabolism at the UK Medical Research Council in Cambridge and Nestle Research Center, Switzerland. She has 13 patents and 32 publications.  Fiona has a B.S. Microbiology from National University of Ireland, Galway and Ph.D. in Nutritional Science from University College Cork, Ireland.



Stephen Lockett, NCl Optical Microscopy Laboratories. Stephen Lockett received the Ph.D. degree from the Department of Medicine, Birmingham University, England.  He is a Principal Scientist and Director of the Optical Microscopy and Analysis Laboratory at the National Cancer Institute in Frederick, Maryland.  He has published over 120 research papers and has received several international awards.  His research interests include fluorescence microscopy and the development of analysis software for extracting quantitative information from images.



Stephen M. Hewitt, MD, PhD, NCl, is a Clinical Investigator within the Laboratory of Pathology, National Cancer Institute and serves as head of the Experimental Pathology Laboratory. Stephen received his BA from the Johns Hopkins University, and his MD and PhD degrees from the University of Texas Health Science Center, Houston. He completed his residency in Anatomic Pathology at the NCI.  Dr. Hewitt is Editor-in-Chief of the Journal of Histochemistry & Cytochemistry. Dr Hewitt has co-authored over 250 articles and serves on the editorial board of four peer-reviewed journals.